echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of Methyl 4-ChloropyriMidine-5-carboxylate

    The Synthetic Routes of Methyl 4-ChloropyriMidine-5-carboxylate

    • Last Update: 2023-05-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Methyl 4-chloropyrimidine-5-carboxylate is an important intermediate in the production of various chemicals and pharmaceuticals.
    It is widely used as a building block for the synthesis of anti-inflammatory, anti-allergic, and anti-viral drugs, among others.
    The demand for this compound has been increasing in recent years, and as a result, various synthetic routes have been developed to synthesize it in the chemical industry.


    One of the most common methods to synthesize methyl 4-chloropyrimidine-5-carboxylate is through the use of the Leuckart reaction.
    This reaction involves the use of chloroformic acid and sodium hydroxide to convert 4-aminopyrimidine-5-carboxylic acid into methyl 4-chloropyrimidine-5-carboxylate.
    The reaction proceeds in high yield and is relatively simple to carry out.


    Another synthetic route to methyl 4-chloropyrimidine-5-carboxylate involves the use of a modified Birch reduction.
    In this method, 4-chloropyrimidine-5-carboxylic acid is reduced using hydrogen in the presence of a palladium catalyst to produce the desired compound.
    This reduction is less expensive and less hazardous than the Leuckart reaction, and it also provides a high yield of the desired product.


    A third synthetic route to methyl 4-chloropyrimidine-5-carboxylate involves the use of the Williamson ether synthesis.
    In this method, 4-bromopyrimidine-5-carboxylic acid is converted into 4-chloropyrimidine-5-carboxylic acid using hydrogen chloride in the presence of a Lewis acid catalyst.
    The resulting 4-chloropyrimidine-5-carboxylic acid is then reduced using hydrogen in the presence of a palladium catalyst to produce methyl 4-chloropyrimidine-5-carboxylate.
    This method is more cost-effective than the Leuckart reaction, as it eliminates the need for sodium hydroxide.


    In addition to these synthetic routes, other methods have also been developed for the synthesis of methyl 4-chloropyrimidine-5-carboxylate.
    These include the use of microwave irradiation, hydroboration-oxidation, andossidation, and Robinson annulation.
    However, these methods are less commonly used due to various disadvantages such as high cost, low yield, and complexity of the reaction.


    In conclusion, the synthetic routes to methyl 4-chloropyrimidine-5-carboxylate are diverse and varied.
    The Leuckart reaction, modified Birch reduction, and Williamson ether synthesis are the most commonly used methods, offering high yield, low cost, and ease of operation.
    These methods are widely used in the chemical industry for the production of various chemicals and pharmaceuticals, and the demand for methyl 4-chloropyrimidine-5-


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.